Evidence map›Paper›PMID 40048699›Full record

ArticleEndocrinology2025

Role of PROP1 in Postnatal Pituitary Gland Maturation.

Amanda Helen Winningham, Eve Camper Rhoads, Michelle Lynn Brinkmeier, Sebastian Alexis Vishnopolska, Jacob Otto Kitzman, Sally Ann Camper, Maria Ines Perez-Millan

Abstract read
In one paragraph

Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amanda Helen WinninghamDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.ORCID 0000-0001-7629-9588
Eve Camper RhoadsDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.
Michelle Lynn BrinkmeierDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.ORCID 0000-0001-9505-4682
Sebastian Alexis VishnopolskaDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.ORCID 0000-0002-1729-9948
Jacob Otto KitzmanDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.ORCID 0000-0002-6145-882X
Sally Ann CamperDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109-5618, USA.ORCID 0000-0001-8556-3379
Maria Ines Perez-MillanInstitute of Biosciences, Biotechnology and Translational Biology, Department of Physiology, Molecular and Cellular Biology, Faculty of Exact and Natural Sciences, University of Buenos Aires, City of Buenos Aires, CABA CE1428EHA, Argentina.ORCID 0000-0002-0486-109X

Funding

Discovery Pipeline for Genetic Defects in Hypothalamic-pituitary Development Using International Mouse Phenotyping Consortium MiceR01HD108156 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sally A. Camper, SHANNON William DAVIS · 2023 to 2026
$2.6M
Hypopituitarism: role of PROP1 and retinoic acid signaling in regulation of pituitary stem cell differentiationR01HD097096 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAMPER, SALLY A. · 2019 to 2023
$2.2M
NICHD NIH HHS R01 HD097096NICHD NIH HHS R01 HD108156NIH HHS R01 HD097096NIH HHS R01HD108156
6 · The paper itself

Abstract

Mutations in the pituitary-specific transcription factor PROP1 are the most common known cause of hypopituitarism in humans. Prop1 is the first pituitary-specific gene in the hierarchy of transcription factors that regulate pituitary development. It is essential for regulating the transition of pituitary stem cells to hormone-producing cells in an epithelial to mesenchymal-like transition process. It is also critical for activation of the lineage specific transcription factor POU1F1 in early organogenesis. Prop1-deficient mice have pituitary dysmorphology and lack the cells that produce growth hormone (GH), thyroid-stimulating hormone (TSH), and prolactin (PRL). Prop1 is expressed in stem cells postnatally, but it is not known whether postnatal expression is necessary for completion of pituitary gland growth or organ maintenance. We tested whether PROP1 has a role in postnatal pituitary development by generating a conditional allele and deleting a crucial exon after birth. We determined that postnatal expression of Prop1 is important for appropriate expansion of the POU1F1 lineage and for robust expression of TSH, GH, and PRL in the early postnatal period. However, by 2 weeks of age, compensatory proliferation of committed POU1F1-expressing cells, but not SOX2-expressing stem cells, have normalized pituitary function. Thus, PROP1 appears to be dispensable after birth in mice.

Indexed as

Homeodomain ProteinsPituitary GlandAnimalsAnimals, NewbornCell ProliferationGene Expression Regulation, DevelopmentalGrowth HormoneMiceMice, KnockoutProlactinSOXB1 Transcription FactorsThyrotropinTranscription Factor Pit-1Growth HormoneHomeodomain ProteinsProlactinProphet of Pit-1 proteinSOXB1 Transcription FactorsThyrotropinTranscription Factor Pit-1committed progenitorsepithelial to mesenchymal-like transitionPOU1F1-lineageSOX2stem cells

Identifiers

PMID40048699
PMCPMC12235079

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.